Skip to main content

23Andme Holding Co.(ME-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low3.10
Day High3.39
Open:3.15
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Miradorโ€™s Precision Medicines for Immunology & Inflammation
GlobeNewswire
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
GlobeNewswire
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
GlobeNewswire
23andMe to Report Q2 FY2025 Financial Results
GlobeNewswire
23andMe Regains Compliance With Nasdaq Listing Requirements
GlobeNewswire
23andMe Appoints Three New Independent Directors to Board
GlobeNewswire
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
GlobeNewswire
23andMe Announces Completion of 1-for-20 Reverse Stock Split
GlobeNewswire
23andMe Announces 1-for-20 Reverse Stock Split
GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
Newsfile
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (ME) Data Breach

Profile

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.